{"id":"https://openalex.org/W2128903776","doi":"https://doi.org/10.1158/1535-7163.mct-08-0656","title":"Molecular imaging of Bcr-Abl phosphokinase in a xenograft model","display_name":"Molecular imaging of Bcr-Abl phosphokinase in a xenograft model","publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W2128903776","doi":"https://doi.org/10.1158/1535-7163.mct-08-0656","mag":"2128903776","pmid":"https://pubmed.ncbi.nlm.nih.gov/19258427","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2679515"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-08-0656","doi":"https://doi.org/10.1158/1535-7163.mct-08-0656","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-08-0656","pdf_url":"https://aacrjournals.org/mct/article-pdf/8/3/703/1882949/703.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/8/3/703/1882949/703.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112355805","display_name":"Ji Yuan Wu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ji Yuan Wu","raw_affiliation_strings":["1Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041976538","display_name":"David J. Yang","orcid":"https://orcid.org/0000-0001-8308-0621","observed_orcids":["https://orcid.org/0000-0001-8308-0621"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Yang","raw_affiliation_strings":["2Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028442529","display_name":"Laura S. Angelo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura S. Angelo","raw_affiliation_strings":["1Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084111291","display_name":"Saady Kohanim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saady Kohanim","raw_affiliation_strings":["2Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["1Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0044,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.77780596,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"8","issue":"3","first_page":"703","last_page":"710"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase","display_name":"BCR-ABL tyrosine kinase","score":0.968999981880188},{"id":"https://openalex.org/keywords/anti-phosphotyrosine-antibodies","display_name":"anti-phosphotyrosine antibody","score":0.9179999828338623},{"id":"https://openalex.org/keywords/111in-labeled-antibody","display_name":"111In-labeled antibody","score":0.8859999775886536},{"id":"https://openalex.org/keywords/radionuclide-imaging","display_name":"scintigraphy","score":0.875},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/non-receptor-tyrosine-kinase","display_name":"non-receptor tyrosine kinase","score":0.7929999828338623},{"id":"https://openalex.org/keywords/early-prediction-of-treatment-response","display_name":"early treatment response prediction","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.8297960758209229},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6958826184272766},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.6625088453292847},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.5516347885131836},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.49253687262535095},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.4773117005825043},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4666476249694824},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.45841073989868164},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4163757264614105},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4070601463317871},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39722439646720886},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3133438527584076},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2287229597568512},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20337066054344177},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15704834461212158},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10478118062019348},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09466439485549927},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003545","descriptor_name":"Cysteine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003545","descriptor_name":"Cysteine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007205","descriptor_name":"Indium Radioisotopes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016719","descriptor_name":"Radioimmunodetection","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019000","descriptor_name":"Phosphotyrosine","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019000","descriptor_name":"Phosphotyrosine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D020014","descriptor_name":"K562 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-08-0656","doi":"https://doi.org/10.1158/1535-7163.mct-08-0656","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-08-0656","pdf_url":"https://aacrjournals.org/mct/article-pdf/8/3/703/1882949/703.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:19258427","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19258427","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Evaluation Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:2679515","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2679515","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-08-0656","doi":"https://doi.org/10.1158/1535-7163.mct-08-0656","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-08-0656","pdf_url":"https://aacrjournals.org/mct/article-pdf/8/3/703/1882949/703.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G562107762","display_name":"Center for Clinical and Translational Sciences","funder_award_id":"UL1RR024148","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2128903776.pdf","grobid_xml":"https://content.openalex.org/works/W2128903776.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1963561520","https://openalex.org/W1977312224","https://openalex.org/W1982493279","https://openalex.org/W1994309500","https://openalex.org/W1995427942","https://openalex.org/W2001231402","https://openalex.org/W2011089797","https://openalex.org/W2017596184","https://openalex.org/W2020894870","https://openalex.org/W2024133444","https://openalex.org/W2027617390","https://openalex.org/W2030054103","https://openalex.org/W2034092798","https://openalex.org/W2037752525","https://openalex.org/W2039751522","https://openalex.org/W2041222202","https://openalex.org/W2046975598","https://openalex.org/W2051209715","https://openalex.org/W2052728155","https://openalex.org/W2053375461","https://openalex.org/W2056742387","https://openalex.org/W2057017098","https://openalex.org/W2087785208","https://openalex.org/W2089828659","https://openalex.org/W2151153432","https://openalex.org/W2268366848","https://openalex.org/W2312804644","https://openalex.org/W2318299540","https://openalex.org/W2325042887","https://openalex.org/W4240547518"],"related_works":["https://openalex.org/W600829469","https://openalex.org/W2048375012","https://openalex.org/W199756487","https://openalex.org/W2001724204","https://openalex.org/W2151618742","https://openalex.org/W2090462486","https://openalex.org/W2013437081","https://openalex.org/W2558567901","https://openalex.org/W2093522268","https://openalex.org/W2024975901"],"abstract_inverted_index":{"The":[0,152],"purpose":[1],"of":[2,62,74,119,121,129,164,192,211,218],"this":[3,36],"study":[4],"was":[5,41,83,157,169,179],"to":[6,28,155,207],"determine":[7,52],"whether":[8],"the":[9,26,63,75,117,205,209],"Bcr-Abl":[10],"tyrosine":[11,59],"kinase":[12,144],"can":[13,185],"be":[14,33,202],"assessed":[15,147],"by":[16,103,131,148,181],"gamma-imaging":[17],"using":[18,35,45,150],"an":[19],"111In-labeled":[20],"anti-phosphotyrosine":[21],"(APT)":[22],"antibody,":[23],"and":[24,79,87,114,159,190,214],"if":[25,53],"response":[27],"treatment":[29,124],"with":[30,43,109,116,137],"imatinib":[31,81,176],"could":[32,55],"detected":[34],"imaging":[37,149,156],"technique.":[38],"APT":[39],"antibody":[40],"labeled":[42],"111In":[44],"ethylenedicysteine":[46],"(EC)":[47],"as":[48,146],"a":[49,57],"chelator.":[50],"To":[51],"111In-EC-APT":[54,94,98,184],"assess":[56,186],"nonreceptor":[58],"kinase,":[60],"xenografts":[61],"human":[64],"chronic":[65],"myelogenous":[66],"leukemia":[67],"cell":[68],"line":[69],"K562":[70],"were":[71,92],"used.":[72],"gamma-Scintigraphy":[73],"tumor-bearing":[76],"mice,":[77],"before":[78],"after":[80,90,141,162,174],"treatment,":[82,177],"obtained":[84],"1,":[85],"24,":[86],"48":[88,160],"h":[89,161],"they":[91],"given":[93],"(100":[95],"microCi/mouse":[96],"i.v.).":[97],"is":[99],"preferentially":[100],"taken":[101],"up":[102],"Bcr-Abl-bearing":[104],"tumor":[105,167,196],"cells":[106],"when":[107],"compared":[108],"111In-EC-BSA":[110],"or":[111],"111In-EC-IgG1":[112],"controls":[113],"comparable":[115],"level":[118],"uptake":[120],"111In-EC-Bcr-Abl.":[122],"Imatinib":[123],"resulted":[125],"in":[126,204],"decreased":[127],"expression":[128],"phospho-Bcr-Abl":[130],"Western":[132],"blot":[133],"analysis,":[134],"which":[135],"correlated":[136],"early":[138,216],"(4":[139],"days":[140],"starting":[142,175],"imatinib)":[143],"down-regulation":[145,191],"111In-EC-APT.":[151,165],"optimal":[153],"time":[154],"24":[158],"injection":[163],"Although":[166],"regression":[168],"insignificant":[170],"on":[171],"day":[172,182],"4":[173],"it":[178],"marked":[180],"14.":[183],"intracellular":[187],"phosphokinase":[188,193,212],"activity,":[189],"activity":[194,213],"predates":[195],"regression.":[197],"This":[198],"technique":[199],"may":[200],"therefore":[201],"useful":[203],"clinic":[206],"detect":[208],"presence":[210],"for":[215],"prediction":[217],"response.":[219]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}